Investment
Features
FeesSafety
Academy
More
Pluang+

Burcon updates 2026 revenue guidance to $6M, aims for $10M run rate and positive cash flow in 2027

Company Fundamentals
24 Sep 2026
Newsfile Corp
View Source
Bullish
Burcon updates 2026 revenue guidance to $6M, aims for $10M run rate and positive cash flow in 2027

Burcon NutraScience announced the election of its board members and shareholder approval for a $21 million convertible debenture financing to support production expansion. The company updated its 2026 revenue guidance to at least $6 million, with an expected annualized run rate of $10 million by year-end, reflecting investments in production reliability and capacity. Burcon aims to achieve positive cash flow in 2027 as customer demand and commercial activity grow. These steps position Burcon to capitalize on increasing demand for its plant-based protein products.

Burcon NutraScience's recent shareholder meeting and commercial guidance update provide context for market watchers. For readers following the Basic Materials sector, here is Pluang's market snapshot as of Sep 25, 2026 03:13 WIB: of 38 priced US stocks, 9 rose and 29 fell. Notable movers include CF Industries Holdings at USD 122.84 with a 0% Sell / 100% Buy order activity, Harmony Gold Mining Co. at USD 19.72 with 1% Sell / 99% Buy, and Agnico Eagle Mines Ltd at USD 196.00 with 29% Sell / 71% Buy.

More News

Costco beats Q4 EPS estimates with $6.75 despite slight revenue miss, driven by strong sales growth and tariff refunds.

Costco beats Q4 EPS estimates with $6.75 despite slight revenue miss, driven by strong sales growth and tariff refunds.

Costco reported a strong Q4 earnings per share (EPS) of $6.75, surpassing analyst expectations of $6.54, helped by tariff refunds. Although quarterly revenue of $93.87 billion slightly missed the $94.97 billion forecast, net sales rose 11.2% year-ove...

Company Fundamentals
Bullish
2 hours ago
Vistry Group cuts profit forecast after £661m H1 loss and plans strategic downsizing.

Vistry Group cuts profit forecast after £661m H1 loss and plans strategic downsizing.

Vistry Group reported a significant first-half pre-tax loss of £661.3 million, driven by a £475 million goodwill impairment and increased building safety costs. Revenue fell to £1.42 billion, and operational performance weakened with fewer home compl...

Company Fundamentals
Bearish
3 hours ago
Vail Resorts expects a loss with flat revenue in upcoming Q3 earnings report on Sept 28, 2026.

Vail Resorts expects a loss with flat revenue in upcoming Q3 earnings report on Sept 28, 2026.

Vail Resorts is set to report its Q3 2026 earnings on September 28, with analysts forecasting a loss per share around -$5.30 and revenue near $271 million, indicating flat performance year-over-year. The company’s financial health shows a high Debt-t...

Company Fundamentals
Bearish
3 hours ago
Gene therapy sura-vec shows lasting improvement in diabetic retinopathy after one treatment, no serious side effects.

Gene therapy sura-vec shows lasting improvement in diabetic retinopathy after one treatment, no serious side effects.

REGENXBIO announced positive 3-year results from its Phase II ALTITUDE trial of surabgene lomparvovec (sura-vec) for non-proliferative diabetic retinopathy (NPDR). A single in-office gene therapy dose led to over 60% of participants achieving more th...

Company Fundamentals
Bullish
4 hours ago
Ethereum breaks year-long pattern with higher high, eyes $3,400 but daily momentum warns of pullback.

Ethereum breaks year-long pattern with higher high, eyes $3,400 but daily momentum warns of pullback.

Ethereum (ETH) has printed its first higher high since its August 2025 peak, breaking a year-long pattern of lower highs. It surpassed the $2,438 resistance level, which has now turned into support, signaling a more bullish weekly structure. However,...

Technical Signals
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App